Advertisement

Topics

Companies Related to "Gut Microbiota and Multiple Sclerosis" [Most Relevant Company Matches] RSS

01:58 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Gut Microbiota and Multiple Sclerosis" found in our extensive corporate database of over 50,000 company records.

Showing "Microbiota Multiple Sclerosis" Companies 1–25 of 1,000+

Extremely Relevant

Familia Unida

Familia Unida living with Multiple Sclerosis (FULWMS) is the first bilingual, English/Spanish Multiple Sclerosis non-profit organization. It serves over thousands of individuals and families affected by Multiple Sclerosis (MS) and other disabilities.


Relevant

Jack S. Burks, MD

Jack Burks, MD is a neurologist, researcher, author, and one of the foremost authorities in Multiple Sclerosis who lectures and consults internationally on Multiple Sclerosis research and patient care issues related to Multiple Sclerosis. He holds numerous positions including:) Board Certified Neurologist (American Board of Neurology and Psychiatry) ) Certified in Neurological Rehabilitation (Amer...

Premier Biomedical, Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed t...


Da Volterra

Headquartered in Paris (France), Da Volterra is a clinical-stage biopharmaceutical company whose vision is to be a trusted and acknowledged leader in the microbiota field. Da Volterra develops novel strategies aimed at protecting the intestinal microbiota and preventing multi-resistant and life-threatening infections for which the medical need is increasing. https://davolterra.com

Eva & Estela Wear Ur Love

Eva & Estela Wear Ur Love is a growing, family-owned t-shirt and apparel business created to raise awareness for multiple sclerosis. Eva & Estela Wear Ur Love is the entrepreneurial endeavor of Kristen Sitarski-Munoz of Williamstown, NJ. Sitarski-Munoz and her husband Ryan faced the simultaneous struggle of job losses and Ryan’s diagnosis of multiple ...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

Premier Biomedical Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, in collaboration with the University of Texas at El Paso and US Department of Defense, specifically targeting the treatment of Alzheimer's disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (...

Acorda Therapeutics, Inc.

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and other nervous system disorders. The Company's marketed products include AMPYRA®(dalfampridine) Extended Release Tablets, 10 mg, a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS); this w...

Consortium of Multiple Sclerosis Centers

Multiple Sclerosis Association of America

International Multiple Sclerosis Management Practice

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis, www.acceleratedcure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Accelerated Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians....

Chromos

Chromos is a biopharmaceutical company with two drug development programs focused on inflammatory diseases and thrombotic disorders. BUSINESS FOCUS Developing biological therapies for the treatment of multiple sclerosis (MS), thrombotic disorders and other inflammatory diseases . PROPRIETARY PRODUCTS Two humanized monoclonal antibodies with novel mechanisms of action. CHR-1103 is being developed i...

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and realizing the potential of its scientific discoveries to benefit patients and shareholders. The company has two business units: BioNeurology, focused on Alzheimer’s and Parkinson...

Apitope

Apitope International NV, based in Belgium and the UK, is a world-class drug developer of immunotherapies for the treatment of autoimmune and allergic diseases, including multiple sclerosis, factor VIII intolerance, uveitis and Graves’ disease. The Company has a patented discovery platform which enables selection of disease-modifying peptide therapies...

Accelerated Cure Project for MS (ACP)

ACP is a nonprofit organization whose mission is to accelerate research efforts to improve the quality of life for people with multiple sclerosis (MS), to cure the disease and, ultimately, to prevent it.

Phase 2 Discovery, Inc.

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).At P2D, we are using our understanding of the treatme...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

AVONEX

It takes just a few minutes to gain access to helpful site features like the MS Mentor and Advocate programs, and other educational information. You'll receive information about site updates, events in your area and more. And the more we can learn about people like you who visit this site, the better we can make it for others who have multiple sclerosis.

Serono Laboratories (UK) Limited

We are one of the world’s top three biotechnology companies, with revenues of USD 1.38 billion (2001).We currently focus on three core therapeutics areas:Reproductive Health Multiple Sclerosis Growth & Metabolism We are also investing strongly in the future, as expressed by our New Therapeutic Areas.Global reach We operate in 45 countries and have sales in over 100 countries.

Serono Japan Company Limited

We are one of the world’s top three biotechnology companies, with revenues of USD 1.38 billion (2001).We currently focus on three core therapeutics areas:Reproductive Health Multiple Sclerosis Growth & Metabolism We are also investing strongly in the future, as expressed by our New Therapeutic Areas.Global reach We operate in 45 countries and have sales in over 100 countries.

Glycominds Ltd.

Glycominds, a commercial stage molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

Myelin Repair Foundation

The Myelin Repair Foundation (MRF) ‐ http://www.myelinrepair.org ‐ is a Northern California‐based, non‐profit research organization focused on accelerating discovery and development of myelin repair therapeutics for multiple sclerosis. Its Accelerated Research Collaboration™ (ARC™) model is designed to optimize the entire process ...

Tosk Incorporated

Neurodegenerative diseases and cancer. The Company’s AON QTS technology not only targets the neurodegeneration process, which will allow discovered drugs to be applicable to a variety of AON diseases caused by different initial events (e.g., Alzheimer’s, Parkinson’s, multiple sclerosis, etc.), but also optimizes the rational drug design approach by selecting for drugs based on their therapeu...


More From BioPortfolio on "Gut Microbiota and Multiple Sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks